Fabian, Kellsye P
Padget, Michelle R
Donahue, Renee N.
Solocinski, Kristen
Robbins, Yvette
Allen, Clint T.
Lee, John H.
Rabizadeh, Shahrooz
Soon-Shiong, Patrick
Schlom, Jeffrey http://orcid.org/0000-0001-7932-4072
Hodge, James W http://orcid.org/0000-0001-5282-3154
Clinical trials referenced in this document:
Documents that mention this clinical trial
727 Resistance to enzalutamide and abiraterone drives tumor phenotypic plasticity and resistance to immune-mediated cytotoxicity
https://doi.org/10.1136/jitc-2021-sitc2021.727
Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC)
https://doi.org/10.1136/jitc-2021-002374
Fulvestrant increases the susceptibility of enzalutamide-resistant prostate cancer cells to NK-mediated lysis
https://doi.org/10.1136/jitc-2023-007386
710 Differences in the susceptibility of human small cell lung cancer variants to NK cell-mediated lysis can be overcome with the addition of N803 (IL-15 superagonist)
https://doi.org/10.1136/jitc-2021-sitc2021.710
Exploiting off-target effects of estrogen deprivation to sensitize estrogen receptor negative breast cancer to immune killing
https://doi.org/10.1136/jitc-2020-002258
840 A therapeutic humanized anti-carcinoma monoclonal antibody (mAb) can also identify immunosuppressive regulatory T (Tregs) cells and down regulate Treg-mediated immunosuppression
https://doi.org/10.1136/jitc-2021-sitc2021.840
Circulating immune cell landscape in patients who had mild ischaemic stroke
https://doi.org/10.1136/svn-2021-001224
PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations
https://doi.org/10.1136/jitc-2019-000450
Documents that mention this clinical trial
PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations
https://doi.org/10.1136/jitc-2019-000450
Funding for this research was provided by:
National Cancer Institute (Intramural Research Program)